NEW YORK; Jan. 10, 2018 – When launching new products, pharmaceutical companies should focus more on evidence-based solutions than just the product or brand, according to a new report from Accenture (NYSE: ACN) on product launches in the pharmaceutical industry.
SAN FRANCISCO; Jan. 8, 2018 – Nanowear has been named the Innovation Champion of the Accenture (NYSE: ACN) HealthTech Innovation Challenge, which pairs leading-edge startups with prominent health and life sciences organizations to develop innovative technology solutions that improve the way people access and manage healthcare.
NEW YORK; Dec. 20, 2017 – Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.
TOKYO; Dec. 11, 2017 – Accenture (NYSE: ACN) has signed consulting and strategic outsourcing agreements with Shionogi & Co., Ltd. ("Shionogi") and its subsidiary company, Shionogi Digital Science Co., Ltd. ("Shionogi Digital Science”) to help Shionogi with its digital transformation initiative.
NEW YORK; Nov. 7, 2017 – Accenture (NYSE: ACN) has launched the Patient Experience Manager which gives life sciences companies a single view of patient interactions, enabling them to make real time improvements in the patient experience by evaluating and optimizing the effectiveness of each interaction.
NEW YORK; Oct. 3, 2017 – Accenture (NYSE: ACN) today announced it is working with Veeva Systems (NYSE: VEEV), a leader in cloud-based software for the global life sciences industry, to bring Veeva Vault RIM – a transformative regulatory information management solution – to biopharma companies. The collaboration will help enable the industry to bring new medicines to patients faster.
NEW YORK; Sept. 7, 2017 – New research from Accenture finds healthcare professionals’ lack of awareness is limiting the usage of patient services (such as adherence programs and remote monitoring) offered by pharmaceutical companies. This is a critical disconnect as patients and pharmaceutical companies primarily rely on healthcare professionals to provide information to their patients on support services.
NEW YORK; Aug. 14, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer in a new Everest Group report on information technology (IT) service providers in the life sciences clinical and R&D industry.
NEW YORK; July 31, 2017 – Accenture (NYSE: ACN) has been named a Leader and Star Performer among 21 providers of life sciences information technology (IT) application services, in the latest Everest Group report: Life Sciences IT Applications Services – Service Provider Landscape with PEAK Matrix™ Assessment 2017. Accenture is positioned above all competitors in life sciences IT application service providers, based on its scale of operations, scope of services, investments in technology, global delivery footprint and buyer satisfaction.
We were unable to find a match for \"$searchstring.\" Try searching again by using different or more general keywords and check for spelling errors.
You must be logged in to view this item.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.